RLX Technology's third quarter 2026 results mark a pivotal moment in the company's transition from a China-centered e-vapor maker to an integrated global platform. The July consolidation of its Western European distribution business transformed the revenue base, with international markets now accounting for the large majority of sales. In my view, the quarter illustrates both the scale opportunity and the profitability trade-off of that expansion: revenue surged, but margins compressed as lower-margin distribution activity entered the mix. The report also arrives as regulators in Europe tighten standards and the U.K. implements a new vaping duty, making compliance and execution central to the investment story.
RLX Technology reported third quarter 2026 net revenue of RMB1.92 billion, a 69.7% increase from RMB1.13 billion in the prior-year period and an 89.7% sequential jump. The company attributed the growth primarily to the consolidation of its newly acquired Western European distribution business, which lifted international revenue to 86.5% of the total. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Gross profit rose 26.7% year over year to RMB446.6 million, but gross margin narrowed to 23.3% from 31.2%. Management noted the decline reflects the structural shift toward distribution, which carries lower margins than branded products, as well as a one-time non-cash inventory fair value step-up of RMB43.5 million related to the acquisition. On a non-GAAP basis, gross margin was roughly 25% or higher.
GAAP net income declined to RMB160.7 million, or RMB0.123 per diluted share, from RMB203.2 million, or RMB0.157 per share, a year earlier. Non-GAAP net income reached RMB235.6 million. Total operating expenses climbed to RMB407.1 million from RMB259.3 million, driven by higher salary and welfare costs, expanded logistics, and transaction-related consulting fees. Net cash from operating activities rebounded to RMB40.0 million after an outflow of RMB63.2 million in the second quarter.
Despite the record revenue figure, RLX shares slipped about 2.05% in premarket trading to $1.43, leaving the stock near the lower end of its 52-week range of $1.40 to $2.55. The muted reaction suggests investors focused more on the margin compression and rising operating costs than on top-line growth. With the stock trading near its 52-week low, sentiment remains cautious, and the market appears to be waiting for clearer evidence that the expanded scale will translate into more consistent profitability and margin recovery.
Looking ahead, RLX has outlined several priorities for 2027 centered on European margin improvement and category expansion. Management expects meaningful margin expansion in Europe next year as acquisition-related inventory cycles through and operational synergies begin to materialize, supported by supply-chain optimization and capital deployment into the distribution platform.
Regulatory transitions will be a key variable. The U.K. Vaping Products Duty took effect in October, with a six-month transition period running through March 2027. Management views the duty as a long-term catalyst that could favor compliant operators by pressuring undercapitalized rivals, though it is also expected to cause transitional working capital absorption in the near term.
Investors should also monitor foreign-exchange effects, since 86.5% of revenue is international while costs are primarily RMB-denominated. Currency depreciation against the RMB creates a passive translation headwind on reported revenue and gross margin. Finally, the company's capital allocation framework — balancing M&A, share repurchases, and dividends while committing to return at least 100% of non-GAAP net income annually — will remain a focal point as management evaluates a dividend in the first half of next year.
I frequently turn to Tickeron’s AI Screener when evaluating earnings-driven names like this one. It helps filter for comparable setups across technical patterns, fundamentals, and AI signals, making it easier to spot ideas that align with my own screening criteria without spending hours on manual reviews.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RLX declined for three days, in 201 of 253 cases, the price declined further within the following month. The odds of a continued downward trend are 79%.
The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RLX as a result. In 72 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.
The Moving Average Convergence Divergence Histogram (MACD) for RLX turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 42 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
The Aroon Indicator for RLX entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where RLX advanced for three days, in 140 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
RLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.127) is normal, around the industry mean (-7.297). P/E Ratio (2.155) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.595). RLX's Dividend Yield (0.248) is considerably higher than the industry average of (0.060). P/S Ratio (3.162) is also within normal values, averaging (2.780).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. RLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Tobacco